BPLEX vs. CRIHX

Last updated Jun 24, 2026

BPLEX (Boston Partners Long/Short Equity Fund) and CRIHX (CRM Long/Short Opportunities Fund) are both Long-Short funds. Over the past 5 years, BPLEX returned 26.13%/yr vs 7.03%/yr for CRIHX. A 0.58 correlation means they provide meaningful diversification when combined. BPLEX charges 2.21%/yr vs 1.60%/yr for CRIHX.

Performance

BPLEX vs. CRIHX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Boston Partners Long/Short Equity Fund (BPLEX) and CRM Long/Short Opportunities Fund (CRIHX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both investments are quite close, with BPLEX having a 13.85% return and CRIHX slightly higher at 13.95%.

BPLEX

• 1D: 0.25%
• 1M: 4.17%
• YTD: 13.85%
• 6M: 13.96%
• 1Y: 32.16%
• 3Y*: 37.08%
• 5Y*: 26.13%
• 10Y*: 14.07%

CRIHX

• 1D: 0.07%
• 1M: 4.63%
• YTD: 13.95%
• 6M: 12.88%
• 1Y: 21.61%
• 3Y*: 10.05%
• 5Y*: 7.03%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BPLEX vs. CRIHX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BPLEX Boston Partners Long/Short Equity Fund	13.85%	27.87%	56.97%	14.93%	6.95%	31.73%	-5.82%	8.97%	-15.70%	2.54%
CRIHX CRM Long/Short Opportunities Fund	13.95%	-1.55%	17.72%	6.06%	-4.24%	5.91%	20.44%	12.95%	-8.43%	4.49%

Correlation

The correlation between BPLEX and CRIHX is 0.57, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.57
Correlation (3Y) Calculated over the trailing 3-year period	0.63
Correlation (5Y) Calculated over the trailing 5-year period	0.62
Correlation (All Time) Calculated using the full available price history since Aug 22, 2016	0.58

The correlation between BPLEX and CRIHX has been stable across timeframes, ranging from 0.57 to 0.63 - a consistent structural relationship.

Return for Risk

BPLEX vs. CRIHX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BPLEX

BPLEX Risk / Return Rank: 94
BPLEX Sharpe Ratio Rank: 96
BPLEX Sortino Ratio Rank: 95
BPLEX Omega Ratio Rank: 87
BPLEX Calmar Ratio Rank: 97
BPLEX Martin Ratio Rank: 96

CRIHX

CRIHX Risk / Return Rank: 39
CRIHX Sharpe Ratio Rank: 37
CRIHX Sortino Ratio Rank: 41
CRIHX Omega Ratio Rank: 36
CRIHX Calmar Ratio Rank: 46
CRIHX Martin Ratio Rank: 37

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BPLEX vs. CRIHX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Boston Partners Long/Short Equity Fund (BPLEX) and CRM Long/Short Opportunities Fund (CRIHX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BPLEX	CRIHX	Difference
Sharpe ratio: Return per unit of total volatility	3.15	1.63	+1.52
Sortino ratio: Return per unit of downside risk	4.83	2.49	+2.34
Omega ratio: Gain probability vs. loss probability	1.57	1.29	+0.28
Calmar ratio: Return relative to maximum drawdown	6.35	2.48	+3.86
Martin ratio: Return relative to average drawdown	22.77	7.60	+15.16

BPLEX vs. CRIHX - Sharpe Ratio Comparison

The current BPLEX Sharpe Ratio is 3.15, which is higher than the CRIHX Sharpe Ratio of 1.63. The chart below compares the historical Sharpe Ratios of BPLEX and CRIHX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BPLEX vs. CRIHX - Drawdown Comparison

The maximum BPLEX drawdown since its inception was -43.47%, which is greater than CRIHX's maximum drawdown of -21.33%. Use the drawdown chart below to compare losses from any high point for BPLEX and CRIHX.

Drawdown Indicators

	BPLEX	CRIHX	Difference
Max Drawdown Largest peak-to-trough decline	-43.47%	-21.33%	-22.14%
Max Drawdown (1Y) Largest decline over 1 year	-5.23%	-9.07%	+3.84%
Max Drawdown (3Y) Largest decline over 3 years	-28.78%	-15.87%	-12.91%
Max Drawdown (5Y) Largest decline over 5 years	-28.78%	-15.87%	-12.91%
Max Drawdown (10Y) Largest decline over 10 years	-37.65%	—	—
Current Drawdown Current decline from peak	-1.07%	0.00%	-1.07%
Average Drawdown Average peak-to-trough decline	-6.60%	-4.11%	-2.49%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.46%	2.96%	-1.50%

Volatility

BPLEX vs. CRIHX - Volatility Comparison

The current volatility for Boston Partners Long/Short Equity Fund (BPLEX) is 4.03%, while CRM Long/Short Opportunities Fund (CRIHX) has a volatility of 5.73%. This indicates that BPLEX experiences smaller price fluctuations and is considered to be less risky than CRIHX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BPLEX	CRIHX	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.03%	5.73%	-1.70%
Volatility (6M) Calculated over the trailing 6-month period	8.37%	10.38%	-2.01%
Volatility (1Y) Calculated over the trailing 1-year period	10.56%	13.82%	-3.26%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	37.89%	11.29%	+26.60%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	29.30%	11.17%	+18.13%

BPLEX vs. CRIHX - Expense Ratio Comparison

BPLEX has a 2.21% expense ratio, which is higher than CRIHX's 1.60% expense ratio.

Dividends

BPLEX vs. CRIHX - Dividend Comparison

BPLEX's dividend yield for the trailing twelve months is around 9.61%, while CRIHX has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BPLEX Boston Partners Long/Short Equity Fund	9.61%	10.94%	58.72%	28.35%	15.19%	5.11%	44.84%	11.33%	9.69%	0.83%	0.00%	9.91%
CRIHX CRM Long/Short Opportunities Fund	0.00%	0.00%	8.11%	2.32%	1.55%	0.75%	8.83%	0.03%	1.75%	0.24%	0.00%	0.00%

Frequently Asked Questions

Can I hold both BPLEX and CRIHX in my portfolio?

BPLEX and CRIHX have a correlation of 0.57, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BPLEX or CRIHX?

CRIHX has higher volatility (5.73%) compared to BPLEX (4.03%). In terms of maximum drawdown, BPLEX dropped -43.47% vs CRIHX's -21.33%.

Which has better risk-adjusted returns?

BPLEX currently has the higher Sharpe Ratio (3.15 vs 1.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.